Humacyte Ratios (2020-2026) | HUMA

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter)
71.57%29.24%65.47%-1,844.75%-311.72%
EBT Margin (Quarter)
-9,022.41%-4,939.65%-10,445.18%-3,507.57%-7,157.60%-6,237.58%
EBIT Margin (Quarter)
-8,524.07%-4,487.43%-9,876.08%-3,239.04%-6,603.00%-5,845.45%
EBITDA Margin (Quarter)
-13,096.68%7,570.41%-12,510.96%-2,325.37%-6,603.00%-5,845.45%
Operating Margin (Quarter)
-8,524.07%-4,487.43%-9,876.08%-3,239.04%-6,603.00%-5,845.45%
Net Margin (Quarter)
-9,022.41%-4,939.65%-10,445.18%-3,507.57%-7,157.60%-6,237.58%
FCF Margin (Quarter)
-12,673.03%-5,576.02%-8,964.12%-3,181.01%-5,593.36%-5,106.87%
Efficiency
Inventory Average (Quarter)
9.55M14.75M20.45M21.45M
Assets Average (Quarter)
100.59M201.94M294.95M275.50M255.42M236.29M215.26M193.64M175.54M158.75M138.80M144.84M149.87M126.52M126.32M150.21M150.67M115.15M103.94M113.46M
Equity Average (Quarter)
-372.64M-151.95M99.02M113.03M123.08M130.47M117.80M99.41M71.50M49.05M25.27M19.85M-1.07M-46.00M-58.20M-8.31M20.05M-0.35M-0.82M7.37M
Invested Capital (Quarter)
-379.76M79.75M145.27M133.89M172.26M147.24M138.03M81.89M97.36M74.28M32.45M84.11M31.79M-1.60M-52.67M102.41M72.59M25.05M38.55M47.49M
Asset Utilization Ratio (Quarter)
0.010.000.000.010.010.020.02
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-15.86-17.06-15.49-15.20-12.45-14.32-12.70-13.25-15.63-16.83-15.16-14.64-11.73-12.40-11.20-7.73-11.68-9.34-9.97-12.74
Debt to Equity (Quarter)
0.240.220.270.200.240.070.360.592.852.22-2.12-0.97-1.241.8416.92-4.37
Debt Ratio (Quarter)
0.060.100.100.110.130.040.160.220.300.360.430.540.470.410.490.23
Equity Ratio (Quarter)
-3.780.250.430.390.580.520.570.450.360.250.110.16-0.20-0.56-0.380.220.03-0.050.030.11
Times Interest Earned (Quarter)
-15.86-17.06-15.49-15.20-12.45-14.32-12.70-13.25-15.63-16.83-15.16-14.64-11.73-12.40-11.20-7.73-11.68-9.34-9.97-12.74
Valuation
Enterprise Value (Quarter)
-100.41M-240.40M-225.50M-206.22M-189.03M-171.73M-151.88M-131.68M-114.60M-100.00M-80.45M-115.50M-93.56M-20.60M-44.94M-62.80M-38.03M-19.50M-50.50M-48.54M
Return Ratios
Return on Sales (Quarter)
-0.90%-0.95%-4.84%-0.49%-1.04%-0.35%-0.72%-0.62%
Return on Capital Employed (Quarter)
-56.29%-33.11%-28.60%-31.43%-33.75%-39.11%-43.23%-50.19%-56.99%-65.93%-83.12%-79.62%-80.90%-106.55%-107.56%-85.29%-85.86%-117.69%-126.40%-117.08%
Return on Assets (Quarter)
-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter)
0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.04%-0.05%1.03%0.03%0.02%0.14%-0.06%3.24%1.42%-0.17%